IL2 and neoplasm: Previous experiments in our lab have shown that TPV recombinants, including one that expresses mouse IL-2 with the viral thymidine kinase gene (66R) deleted, were effective at inducing significant tumor regression in an outbred immune-deficient nude mouse model [3,4].